Lloyd Greene

Affiliations: 
Columbia University, New York, NY 
Area:
neuronal death, neural development
Google:
"Lloyd Greene"
Mean distance: 14.44 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sun X, Jefferson P, Zhou Q, et al. (2019) Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD. Molecular Cancer Research : McR
Sun X, Angelastro JM, Merino D, et al. (2019) Dominant-negative ATF5 rapidly depletes survivin in tumor cells. Cell Death & Disease. 10: 709
Corona C, Pasini S, Liu J, et al. (2018) Activating Transcription Factor 4 (ATF4) regulates neuronal activity by controlling GABAR trafficking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Liu J, Amar F, Corona C, et al. (2018) Brain-Derived Neurotrophic Factor Elevates Activating Transcription Factor 4 (ATF4) in Neurons and Promotes ATF4-Dependent Induction of. Frontiers in Molecular Neuroscience. 11: 62
Biswas SC, Sanphui P, Chatterjee N, et al. (2017) Cdc25A phosphatase: a key cell cycle protein that regulates neuron death in disease and development. Cell Death & Disease. 8: e2692
Chatterjee N, Sanphui P, Kemeny S, et al. (2016) Role and regulation of Cdc25A phosphatase in neuron death induced by NGF deprivation or β-amyloid. Cell Death Discovery. 2: 16083
Pasini S, Liu J, Corona C, et al. (2016) Activating Transcription Factor 4 (ATF4) modulates Rho GTPase levels and function via regulation of RhoGDIα. Scientific Reports. 6: 36952
Karpel-Massler G, Horst BA, Shu C, et al. (2016) A synthetic cell-penetrating dominant-negative ATF5 peptide exerts anti-cancer activity against a broad spectrum of treatment resistant cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Cates CC, Arias AD, Nakayama Wong LS, et al. (2016) Regression/Eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide. Oncotarget
Aimé P, Sun X, Zareen N, et al. (2015) Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 10731-49
See more...